Educational information, not medical advice — ask your doctor or midwife.
Fadogia agrestis is a shrubby plant native to Nigeria and other parts of West Africa, where traditional healers have long used the stem bark to support male sexual vitality and fertility. It gained significant Western attention after animal research suggested it could raise luteinizing hormone (LH) and testosterone levels. While it remains popular in men's health and sports nutrition circles, human clinical trial data is currently very limited.
The plant's saponins and alkaloids are thought to stimulate the body's own testosterone-producing pathways — specifically by encouraging the pituitary to release more luteinizing hormone (LH), which in turn signals the testes to produce more testosterone. This is different from directly supplying hormones — it nudges your own system to do the work. Some compounds may also have antioxidant effects that protect reproductive tissue.
Most commercial products come as capsules or tablets standardized to stem extract (commonly 400–600 mg per serving). Loose powder is also available for stacking with other supplements. There is no standardized extract potency used across the industry, which makes comparing products difficult. Quality and purity vary considerably between brands.
In Nigerian folk medicine, Fadogia agrestis stem decoctions have been prepared and consumed by men seeking to enhance sexual performance and fertility for generations. The plant features in the traditional medicine systems of multiple West African communities under local names such as 'bakin gagai' in Hausa-speaking regions. Western supplement markets discovered it in the 2000s following animal research, and its popularity surged further in the 2020s through podcast and sports nutrition communities.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.